About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Tags Biotech and Pharmaceuticals Health & Science Companies
From CNBC.com News
Wegovy-maker Novo Nordisk sales soar 30% on strong demand for its weight-loss drug
Tags Health care industry Novo Nordisk A/S Health & Science
From CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
Tags Medicare health plans Health insurance Health care industry
From CNBC.com News
Obesity drug Wegovy's landmark trial result could 'open up' health insurance access, analyst says
Tags Drug Retail Business News Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves midday: Beyond Meat, Chegg, PNC Financial, Dish & more
Tags Novo Nordisk A/S M&T Bank Corp PNC Financial Services Group Inc
From CNBC.com News
Stocks making the biggest moves premarket: UPS, Lucid, Beyond Meat, Novo Nordisk and more
Tags Stock markets Sagimet Biosciences Inc Market Insider
From CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
Tags Clinical trials Weight management Business News
From CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
Tags Suicides Health & Science Science
From CNBC.com News
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
Tags Eli Lilly and Co Health & Science Europe: Top News And Analysis
From CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Tags Mergers and acquisitions Obesity Pharmaceuticals
From CNBC.com News
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
Tags Business News Diabetes Politics
From CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
Tags Mental health Law and Regulation Novo Nordisk A/S
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Business US: News Social issues
From CNBC.com News
Stocks making the biggest moves midday: Shutterstock, Newell Brands, Zillow and more
Tags Amazon/com Inc WD/40 Co Finance
From CNBC.com News
European regulator to review weight-loss drugs following reports of suicidal thoughts
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Moderna strikes deal to develop mRNA drugs in China
Tags Merck & Co Inc Foreign policy Business News
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags Eli Lilly and Co Health & Science Biotech and Pharmaceuticals
From CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
Tags Weight management Business News Pfizer Inc
From CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Tags Business US: News Companies
From CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Tags Health & Science Science Biotech and Pharmaceuticals
From CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Tags Pfizer Inc Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
Tickers LAW LAWS
Tags Business News Health care industry Laws
From CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
Tags Business US: News Companies
From CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Tags Diabetes Business News Politics
From CNBC.com News
Novo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars
Tags Business News Medicine Business
From CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
Tags Biotech and Pharmaceuticals Health Care Services Pharmaceuticals
From CNBC.com News
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds
Tags US: News Business US Top News and Analysis
From CNBC.com News
Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices
Tags Epidemics Diabetes Politics
From CNBC.com News
Senate legislation would cap insulin at $35 per month for people with private insurance
Tags Eli Lilly and Co Social issues Business
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.